Ruben Ekbråten has been appointed as the new Chief Executive Officer (CEO) of DiaGenic ASA effective from February 01, 2014. The appointment is temporary for 2 months. Ruben Ekbråten holds the position as Chief Financial Officer (CFO) in DiaGenic ASA. In addition to his 6 years tenure at DiaGenic he has international experience from several positions within finance at GE Healthcare.

The company announced that it will move to new facilities effective from February 1, 2014. The new address for the company is Sj-lyst plass 2, 0278 Oslo, Norway.